Vita 34 AG
XETRA:V3V
Relative Value
The Relative Value of one
V3V
stock under the Base Case scenario is
hidden
EUR.
Compared to the current market price of 5.3 EUR,
Vita 34 AG
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
V3V Competitors Multiples
Vita 34 AG Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| DE |
|
Vita 34 AG
XETRA:V3V
|
92.4m EUR | 1.1 | 35.8 | 10.5 | -149.8 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
98.6B USD | 0.3 | 210.7 | 13.9 | 13.9 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
65.9B EUR | 0.3 | 12.6 | 8 | 10.2 | |
| US |
|
Cigna Corp
NYSE:CI
|
78.6B USD | 0.3 | 12.7 | 0 | 0 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
28.5B EUR | 1.3 | 24.6 | 10.8 | 16.3 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
23.7B EUR | 1.2 | 32.9 | 10.4 | 22.1 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
24.1B USD | 1.7 | 27.9 | 14.9 | 20.8 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
23.4B USD | 2.2 | 24.8 | 13.3 | 17.9 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
11.7B EUR | 0.6 | 16.1 | 6.4 | 13.7 | |
| US |
|
Guardant Health Inc
NASDAQ:GH
|
13.4B USD | 14.5 | -32.9 | -34.7 | -31.5 | |
| US |
|
DaVita Inc
NYSE:DVA
|
10B USD | 0.7 | 13.5 | 7.2 | 9.7 |